My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
COMPLIANCE INFO_2020
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
L
>
LONGE
>
7910
>
2231-2238 – Tiered Permitting Program
>
PR0536175
>
COMPLIANCE INFO_2020
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
11/16/2021 9:43:30 AM
Creation date
3/3/2020 11:41:06 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2231-2238 – Tiered Permitting Program
File Section
COMPLIANCE INFO
FileName_PostFix
2020
RECORD_ID
PR0536175
PE
2231
FACILITY_ID
FA0012466
FACILITY_NAME
PREMIER FINISHING
STREET_NUMBER
7910
Direction
S
STREET_NAME
LONGE
City
STOCKTON
Zip
95206
APN
17726034
CURRENT_STATUS
01
SITE_LOCATION
7910 S LONGE
P_DISTRICT
001
QC Status
Approved
Scanner
SJGOV\gmartinez
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
350
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
I lrxarelsps3.:�`-cr. l' tae r'denaaspEer <br /> Safety Data Sheet (SDS <br /> ABC® Products of Sacramenti <br /> i <br /> DeOx 710 Rion-Chromated Deoxidizer <br /> SDS Number: 103 Revision Date: 12/26/201, -° <br /> Page 3 of 1( <br /> P403+233 -Store in a well ventilated place. Keep container tightly closed. _ <br /> P405-Store locked up. _ <br /> P501 - Dispose of contents/container to an approved waste disposal plant. <br /> z <br /> — i <br /> COMPOSITIOf1ANFORMATION ON INGREDIENTS <br /> 3 <br /> Ingredients: <br /> Cas if I Percentage I Chemical Name <br /> --10028--22-5 [ 45-55% I Sulfuric acid, iron(3k) salt (3:2) i <br /> 7631-99-4 120-30 I Nitric acid sodium salt <br /> 7681-38-1 I 0-10$ I sulfuric acid, monosodium salt <br /> 16893--85--9 1 0-10% 1 5ilicate(2-) , hexafluoxo-, disodium I <br /> N/A 1 0-350 1 Proprietary, non-hazardous, non-regulated <br /> i <br /> 4 <br /> FIRST AID MEASURES <br /> s i <br /> Inhalation: If symptoms develop, move victim to fresh air. Obtain medical attention. Give oxygen or artificial <br /> respiration if needed. Lie victim down in the recovery position; cover'to keep warm. Show this Safety Date <br /> Sheet to the physician in attendance. <br /> Skin Contact, Get immediate medical attention. Remove contaminated clothing immediately; wash before reuse. <br /> `. Promptly flush skin with water until all chemical is removed. This material can be absorbed through the <br /> skin with resultant toxic effects. Show this Safety Data Sheet to the physician in attendance. <br /> Eye Contact: Get immediate medical attention. Immediately Flush eyes with large amounts of water for at least 15 <br /> minutes, lifting eyelids occasionally to facilitate irrigation. Show this Safety Data Sheet to the physician in <br /> attendance, i <br /> Ingestion: Call a physician immediately. Take victim immediately to hospital. Show this Safety Data Sheet to the <br /> physician in attendance. Prevention of absorption of the Fluoride ion can be obtained by giving a source c <br /> Calcium or Magnesium. <br /> If victim is conscious; <br /> If swallowed, rinse mouth with water(only if the person is conscious). Give to drink one of the following: <br /> 3.4 glasses of milk, chewable calcium carbonate tablets, Milk of Magnesia or a 1% aqueous Calcium <br /> Gluconate solution. Do NOT induce vomiting. Artificial respiration and/or oxygen may be necessary. <br /> If victim in unconscious, but breathing: E <br /> Artificial respiration and/or oxygen may be necessary. i <br /> i <br /> General advice: <br /> Show this Safety Data Sheet to the doctor in attendance. The primary risk of toxic exposure is through ingestion. Conditions <br /> such as hypocalcemia, hypomagnesemia,cardiac arrhythmias and hyperalkemia should be monitored for, since they can occ <br /> after exposure. Renal dialysis may be necessary in some cases. _ <br /> Most important symptoms and effects, both acute and delayed: <br /> The most important known symptoms and effects are described in the labelling (see Section 2) and/or Section 11. <br /> t <br /> F <br /> Indication of any immediate medical attention and special treatment needed: <br /> No data available. <br /> i <br />
The URL can be used to link to this page
Your browser does not support the video tag.